{"id":8140,"date":"2022-07-26T10:05:57","date_gmt":"2022-07-26T02:05:57","guid":{"rendered":"https:\/\/ttic.nhri.edu.tw\/?p=8140"},"modified":"2022-07-26T10:12:53","modified_gmt":"2022-07-26T02:12:53","slug":"dbpr807-a-cxcr4-targeted-antagonist-2","status":"publish","type":"post","link":"https:\/\/ttic.nhri.edu.tw\/en\/dbpr807-a-cxcr4-targeted-antagonist-2\/","title":{"rendered":"Technology Available for Industry-Academia Collaboration or Technology Licensing. \u201cDBPR807: A CXCR4-Targeted Antagonist\u201d (2022\/7\/26)"},"content":{"rendered":"

Technology Available for Industry-Academia Collaboration or Technology Licensing.<\/strong><\/p>\n

\u201cDBPR807: A CXCR4-Targeted Antagonist\u201d<\/strong><\/h5>\n

Date: 2022.7.26<\/strong><\/p>\n

 <\/p>\n

1. Title:<\/strong><\/p>\n

NHRI\u00a0technology, \u201cDBPR807: <\/strong>A CXCR4-Targeted Antagonist<\/strong>\u201d (abbreviated as \u201cThe Technology<\/strong>\u201d) available for industry-academia collaboration or technology licensing.<\/p>\n

 <\/p>\n

2. Description:<\/strong><\/p>\n

DBPR807 is a small molecule CXCR4 antagonist. DBPR807 can significantly suppress tumor growth of hepatocellular carcinoma via reducing angiogenesis, normalizing tumor microenvironment, and promoting cytotoxic T cell infiltration. On the other hand, the rat and mini-pig animal studies demonstrated that DBPR807 possesses anti-inflammatory activity and can be used in acute myocardial infarction.<\/p>\n

 <\/p>\n

3. Potential collaboration partner qualifications:<\/strong><\/p>\n

(1)\u00a0\u00a0\u00a0\u00a0\u00a0be incorporated and approved by law and does not have any record of misconduct or conviction for any offense<\/p>\n

(2)\u00a0\u00a0\u00a0\u00a0\u00a0better to have related experience and skills for developing The Technology<\/strong><\/p>\n

(3)\u00a0\u00a0\u00a0\u00a0\u00a0better to have experience of international collaboration and clinical trial<\/p>\n

(4)\u00a0\u00a0\u00a0\u00a0\u00a0be willing to provide long-term investment<\/p>\n

 <\/p>\n

4. Registration\uff1a<\/strong><\/p>\n

Please contact to Ms. Wan-Ping Hsieh (email: wanping@nhri.edu.tw<\/a>) or Ms. Wen-Chuan Hsieh (email: wenchuan@nhri.edu.tw<\/a>). Address: Technology Transfer and Incubation Center, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan.<\/p>\n

 <\/p>\n

5. Other:<\/strong><\/p>\n